Literature DB >> 6196178

Regulation of terminal differentiation of cultured mouse epidermal cells by 1 alpha,25-dihydroxyvitamin D3.

J Hosomi, J Hosoi, E Abe, T Suda, T Kuroki.   

Abstract

Terminal differentiation of mouse epidermal cells in primary culture was found to be regulated by 1 alpha,25-dihydroxyvitamin D3 (1 alpha,25(OH)2D3), the hormonal form of vitamin D3 produced by sequential hydroxylations in the liver and kidney. Epidermal differentiation was stimulated dose dependently by 1 alpha,25(OH)2D3 at concentrations of 0.12 nM or more. In the presence of the vitamin, stratified foci increased in number and size and contiguous foci coalesced. Basal cells in the treated cultures decreased sharply and underwent differentiation into squamous and enucleated cells which sloughed off into the medium during cultivation. The size and density of the cells became larger and lighter during the course of differentiation. 1 alpha,25(OH)2D3 markedly stimulated formation of a cornified envelope, a structure with chemically stable cross-links formed beneath the plasma membrane. Of several derivatives of vitamin D3 examined, 1 alpha,25(OH)2D3 was the most potent in inducing epidermal differentiation. Stimulation of epidermal differentiation was also observed in low calcium medium. DNA synthesis was inhibited dose dependently by 1 alpha,25(OH)2D3. A specific receptor for 1 alpha,25(OH)2D3 was found in the cytosol fraction of the epidermal cells. Scatchard plot analysis revealed that the receptor has an apparent dissociation constant (Kd value) of 54 pM and maximum binding value (Nmax) of 43 fmol/mg protein. The specificity of the receptor was demonstrated by analog competition in the following order: 1 alpha,25(OH)2D3 much greater than 25-hydroxyvitamin D3 greater than 1 alpha-hydroxyvitamin D3 greater than 24R,25-dihydroxyvitamin D3.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6196178     DOI: 10.1210/endo-113-6-1950

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  75 in total

Review 1.  [Topical treatment of psoriasis: a systematic update].

Authors:  R Aschoff; G Wozel; M Meurer
Journal:  Hautarzt       Date:  2003-02-13       Impact factor: 0.751

2.  Deimination is regulated at multiple levels including auto-deimination of peptidylarginine deiminases.

Authors:  Marie-Claire Méchin; Fanny Coudane; Véronique Adoue; Jacques Arnaud; Hélène Duplan; Marie Charveron; Anne-Marie Schmitt; Hidenari Takahara; Guy Serre; Michel Simon
Journal:  Cell Mol Life Sci       Date:  2010-01-29       Impact factor: 9.261

3.  Inhibitory effect of 1 alpha,25-dihydroxyvitamin D3 on mast cell proliferation and A23187-induced histamine release, also accompanied by a decreased c-kit receptor.

Authors:  N Toyota; H Sakai; H Takahashi; Y Hashimoto; H Iizuka
Journal:  Arch Dermatol Res       Date:  1996-10       Impact factor: 3.017

4.  Tacalcitol (1,24(OH)2D3, TV-02) inhibits phorbol ester-induced epidermal proliferation and cutaneous inflammation, and induces epidermal differentiation in mice.

Authors:  H Sato; I Sugimoto; T Matsunaga; M Tsuchimoto; T Ohta; H Uno; M Kiyoki
Journal:  Arch Dermatol Res       Date:  1996-10       Impact factor: 3.017

5.  Effect of 1 alpha-hydroxycholecalciferol on psoriasis vulgaris: a pilot study.

Authors:  S Takamoto; T Onishi; S Morimoto; S Imanaka; S Yukawa; T Kozuka; Y Kitano; Y Seino; Y Kumahara
Journal:  Calcif Tissue Int       Date:  1986-12       Impact factor: 4.333

6.  Induction of differentiation in normal human keratinocytes by adenovirus-mediated introduction of the eta and delta isoforms of protein kinase C.

Authors:  M Ohba; K Ishino; M Kashiwagi; S Kawabe; K Chida; N H Huh; T Kuroki
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

7.  Topical application of calcitriol alters expression of filaggrin but not keratin K1 in mouse epidermis.

Authors:  C Lützow-Holm; A Heyden; H S Huitfeldt; P Brandtzaeg; O P Clausen
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

8.  Distribution of 1,25-dihydroxyvitamin D3[22-oxa] in vivo receptor binding in adult and developing skin.

Authors:  W E Stumpf; N Koike; N Hayakawa; K Tokuda; K Nishimiya; J Hirate; A Okazaki; K Kumaki
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

9.  1,25-Dihydroxyvitamin D3 upregulates the phosphatidylinositol signaling pathway in human keratinocytes by increasing phospholipase C levels.

Authors:  S Pillai; D D Bikle; M J Su; A Ratnam; J Abe
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

10.  Epidermal differentiation characteristics of the psoriatic plaque during treatment with calcipotriol.

Authors:  C J van der Vleuten; E M de Jong; P C van de Kerkhof
Journal:  Arch Dermatol Res       Date:  1996-06       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.